Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
ABSTRACTTo understand SARS-CoV-2 immunity after natural infection or vaccination, functional assays such as virus neutralising assays are needed. So far, assays to detect SARS-CoV-2 neutralising antibodies rely on cell-culture based infection assays either using wild type SARS-CoV-2 or pseudotyped v...
Main Authors: | Benjamin Meyer, Johan Reimerink, Giulia Torriani, Fion Brouwer, Gert-Jan Godeke, Sabine Yerly, Marieke Hoogerwerf, Nicolas Vuilleumier, Laurent Kaiser, Isabella Eckerle, Chantal Reusken |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1835448 |
Similar Items
-
The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
by: Simon D. Scott, et al.
Published: (2016-12-01) -
Neutralising Neurophobia
by: Greg Lamb
Published: (2018-03-01) -
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
by: Emma M. Bentley, et al.
Published: (2021-08-01) -
Studying longitudinal neutralising antibody levels against Equid herpesvirus 1 in experimentally infected horses using a novel pseudotype based assay
by: Cecilia Di Genova, et al.
Published: (2024-01-01) -
Development of a novel plaque reduction neutralisation test for hantavirus infection
by: Michelly de Pádua, et al.
Published: (2015-08-01)